Related Experiment Videos
Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?
Brigitte Lankat-Buttgereit1, Rüdiger Göke
1Clinical Research Unit for Gastrointestinal Endocrinology, University of Marburg, 35037 Marburg, Germany. lankatbu@mailer.uni-marburg.de
Biology of the Cell
|November 25, 2003
Summary
Program cell death protein 4 (Pdcd4) impacts apoptosis and suppresses cancer by inhibiting protein translation. This review covers Pdcd4
Area of Science:
- Molecular biology
- Cancer research
- Cellular processes
Background:
- Programmed cell death protein 4 (Pdcd4) is a novel gene.
- Pdcd4 was first identified as a differentially expressed protein during apoptosis.
- Pdcd4 has implications in transformation suppression via inhibition of protein translation.
Purpose of the Study:
- To review the current knowledge on Pdcd4.
- To summarize expression, structure, and function of Pdcd4.
- To discuss the potential of Pdcd4 as a molecular target in cancer therapy.
Main Methods:
- Literature review
- Analysis of existing data on Pdcd4 expression
- Review of studies on Pdcd4 structure and function
Main Results:
- Pdcd4 plays a role in programmed cell death.
- Pdcd4 inhibits protein translation, contributing to transformation suppression.
- Pdcd4 exhibits potential as a molecular target for cancer therapy.
Conclusions:
- Pdcd4 is a significant protein involved in apoptosis and cancer suppression.
- Further research into Pdcd4's mechanisms could lead to novel cancer treatments.